Using "old" medications to fight new COVID-19: Re-purposing with a purpose

J Mol Cell Cardiol. 2020 Sep:146:41-42. doi: 10.1016/j.yjmcc.2020.07.005. Epub 2020 Jul 18.
No abstract available

Keywords: ACE inhibitors; COVID-19; Drug treatment; Inflammation; SARS-CoV-2.

Publication types

  • Letter

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / virology
  • Dexamethasone / therapeutic use
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / virology
  • Drug Repositioning
  • Host-Pathogen Interactions / drug effects
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperlipidemias / complications
  • Hyperlipidemias / diagnosis
  • Hyperlipidemias / drug therapy*
  • Hyperlipidemias / virology
  • Hypertension / complications
  • Hypertension / diagnosis
  • Hypertension / drug therapy*
  • Hypertension / virology
  • Hypolipidemic Agents / therapeutic use
  • Obesity / complications
  • Obesity / diagnosis
  • Obesity / drug therapy*
  • Obesity / virology
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / virology
  • SARS-CoV-2

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antiviral Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • remdesivir
  • Adenosine Monophosphate
  • Hydroxychloroquine
  • Dexamethasone
  • Alanine